Positive glycemic outcomes with tubeless insulin pump use have also been observed in a long-term retrospective analysis of the German/Austrian Diabetes Patienten Verlaufsdokumentation (DPV) registry.5 Danne and colleagues reported significantly lower HbA1c, 7.5% versus 7.7%, and TDD of insulin at 1 year in youth who switched to the tubeless insulin management system, compared to those who continued MDI use. Here, INS is linked to diabetes mellitus.